These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4977944)

  • 1. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.
    Elslager EF; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):363-7. PubMed ID: 4977944
    [No Abstract]   [Full Text] [Related]  

  • 2. Respository drugs. IV. 4',4'''-Sulfonylbisacetanilide (Acedapsone, DADDS) and related sulfanilylanilides with prolonged antimalarial and antileprotic action.
    Elslager EF; Gavrilis ZB; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):357-63. PubMed ID: 4892242
    [No Abstract]   [Full Text] [Related]  

  • 3. Repository drugs. VI. 4'-[N-(Aralkylidene-, -Benzylidene-, and -naphthylidene)sulfanilyl]anilides, 4'-[N-[(Dimethylamino)methylene]sulfanilyl]anilides, and related sulfanilylanilides with prolonged antimalarial and antileprotic action.
    Worth DF; Elslager EF; Phillips AA
    J Med Chem; 1969 Jul; 12(4):591-6. PubMed ID: 4978365
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of leprosy.
    Shepard CC
    Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433
    [No Abstract]   [Full Text] [Related]  

  • 5. Repository drugs. VII. N-Allylidene-4,4'-sulfonyldianiline and N-(benzylidene- and -1-naphthylmethylene)-N'-methylene-4,4'-sulfonyldianiline polymers with prolonged antimalarial and antileprotic action.
    Elslager EF; Capps DB; Worth DF
    J Med Chem; 1969 Jul; 12(4):597-9. PubMed ID: 5793147
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones.
    Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE
    J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey.
    Sonntag AC; Stenger VG; Vogh BP; Maren TH
    J Pharmacol Exp Ther; 1972 Jul; 182(1):34-47. PubMed ID: 4625288
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimalarial agents. 8. Ring-substituted bis(4-aminophenyl) sulfones and their precursors.
    Popoff IC; Engle AR; Whitaker RL; Singhal GH
    J Med Chem; 1971 Dec; 14(12):1166-9. PubMed ID: 5116228
    [No Abstract]   [Full Text] [Related]  

  • 10. A bis-N,O-diacetylhydroxylamine analog of diaminodiphenyl sulfone possessing antimalarial activity.
    Loev B; Dowalo F
    J Med Chem; 1973 Feb; 16(2):161-3. PubMed ID: 4566628
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD).
    Ozawa T; Shepard CC; Karat AB
    Am J Trop Med Hyg; 1971 Mar; 20(2):274-81. PubMed ID: 4928595
    [No Abstract]   [Full Text] [Related]  

  • 12. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 13. Repository antimalarial drugs: N,N'-diacetyl-4,4'-diaminodiphenylsulphone and related 4-acylaminodiphenylsulphones.
    Elslager EF; Worth DF
    Nature; 1965 May; 206(984):630-1. PubMed ID: 4953605
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 15. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin.
    Shepard CC; Walker LL; Van Landingham M; Redus MA
    Am J Trop Med Hyg; 1971 Jul; 20(4):616-20. PubMed ID: 4398128
    [No Abstract]   [Full Text] [Related]  

  • 17. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
    Shepard CC; Tolentino JG; McRae DH
    Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
    [No Abstract]   [Full Text] [Related]  

  • 18. Repository drugs. 8. Ester and amide congeners of amodiaquine, hydroxychloroquine, oxychloroquine, primaquine, quinacrine, and related substances as potential long-acting antimalarial agents.
    Elslager EF; Tendick FH; Werbel LM
    J Med Chem; 1969 Jul; 12(4):600-7. PubMed ID: 5793148
    [No Abstract]   [Full Text] [Related]  

  • 19. A new repository antimalarial agent, CI-564, used in a field trial in New Guinea.
    Rieckmann KH
    Trans R Soc Trop Med Hyg; 1967; 61(2):189-98. PubMed ID: 6047753
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance in leprosy.
    Browne SG
    Lepr Rev; 1974 Sep; 45(3):276-8. PubMed ID: 4612275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.